Globus Medical Income from Continuous Operations 2010-2024 | GMED
Globus Medical annual/quarterly income from continuous operations history and growth rate from 2010 to 2024. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
- Globus Medical income from continuous operations for the quarter ending December 31, 2024 was $0.027B, a 76.3% increase year-over-year.
- Globus Medical income from continuous operations for the twelve months ending December 31, 2024 was $0.103B, a 16.19% decline year-over-year.
- Globus Medical annual income from continuous operations for 2024 was $0.103B, a 16.19% decline from 2023.
- Globus Medical annual income from continuous operations for 2023 was $0.123B, a 35.39% decline from 2022.
- Globus Medical annual income from continuous operations for 2022 was $0.19B, a 27.47% increase from 2021.
| Globus Medical Annual Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2024 | $103 |
| 2023 | $123 |
| 2022 | $190 |
| 2021 | $149 |
| 2020 | $102 |
| 2019 | $155 |
| 2018 | $156 |
| 2017 | $107 |
| 2016 | $104 |
| 2015 | $113 |
| 2014 | $92 |
| 2013 | $69 |
| 2012 | $74 |
| 2011 | $61 |
| 2010 | $54 |
| 2009 | $52 |
| Globus Medical Quarterly Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2024-12-31 | $27 |
| 2024-09-30 | $52 |
| 2024-06-30 | $32 |
| 2024-03-31 | $-7 |
| 2023-12-31 | $15 |
| 2023-09-30 | $1 |
| 2023-06-30 | $58 |
| 2023-03-31 | $49 |
| 2022-12-31 | $50 |
| 2022-09-30 | $47 |
| 2022-06-30 | $55 |
| 2022-03-31 | $38 |
| 2021-12-31 | $15 |
| 2021-09-30 | $47 |
| 2021-06-30 | $42 |
| 2021-03-31 | $45 |
| 2020-12-31 | $53 |
| 2020-09-30 | $44 |
| 2020-06-30 | $-21 |
| 2020-03-31 | $26 |
| 2019-12-31 | $46 |
| 2019-09-30 | $38 |
| 2019-06-30 | $38 |
| 2019-03-31 | $33 |
| 2018-12-31 | $37 |
| 2018-09-30 | $35 |
| 2018-06-30 | $45 |
| 2018-03-31 | $40 |
| 2017-12-31 | $24 |
| 2017-09-30 | $26 |
| 2017-06-30 | $29 |
| 2017-03-31 | $29 |
| 2016-12-31 | $24 |
| 2016-09-30 | $26 |
| 2016-06-30 | $26 |
| 2016-03-31 | $28 |
| 2015-12-31 | $38 |
| 2015-09-30 | $26 |
| 2015-06-30 | $24 |
| 2015-03-31 | $25 |
| 2014-12-31 | $28 |
| 2014-09-30 | $23 |
| 2014-06-30 | $21 |
| 2014-03-31 | $21 |
| 2013-12-31 | $21 |
| 2013-09-30 | $20 |
| 2013-06-30 | $7 |
| 2013-03-31 | $20 |
| 2012-12-31 | $21 |
| 2012-09-30 | $16 |
| 2012-06-30 | $19 |
| 2012-03-31 | $18 |
| 2011-12-31 | $14 |
| 2011-09-30 | $17 |
| 2011-06-30 | $16 |
| 2011-03-31 | $14 |
| 2010-12-31 | |
| 2009-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $9.781B | $2.519B |
| Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy. | |||